145 related articles for article (PubMed ID: 27296043)
1. Pharmacological Intervention in Type 2 Diabetes Mellitus - A Pathophysiologically Reasoned Approach?
Forst T; Heise T; Plum-Morschel L
Curr Diabetes Rev; 2016; 12(4):429-439. PubMed ID: 27296043
[TBL] [Abstract][Full Text] [Related]
2. Potential new treatments for type 2 diabetes.
Bailey CJ
Trends Pharmacol Sci; 2000 Jul; 21(7):259-65. PubMed ID: 10871894
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of DPP-4: a new therapeutic approach for the treatment of type 2 diabetes.
Pratley RE; Salsali A
Curr Med Res Opin; 2007 Apr; 23(4):919-31. PubMed ID: 17407649
[TBL] [Abstract][Full Text] [Related]
4. Incretin hormones and maturity onset diabetes of the young--pathophysiological implications and anti-diabetic treatment potential.
Østoft SH
Dan Med J; 2015 Sep; 62(9):. PubMed ID: 26324089
[TBL] [Abstract][Full Text] [Related]
5. Modulation of the pancreatic islet-stress axis as a novel potential therapeutic target in diabetes mellitus.
Ludwig B; Barthel A; Reichel A; Block NL; Ludwig S; Schally AV; Bornstein SR
Vitam Horm; 2014; 95():195-222. PubMed ID: 24559919
[TBL] [Abstract][Full Text] [Related]
6. Review of approved pioglitazone combinations for type 2 diabetes.
Forst T; Hanefeld M; Pfützner A
Expert Opin Pharmacother; 2011 Jul; 12(10):1571-84. PubMed ID: 21639813
[TBL] [Abstract][Full Text] [Related]
7. [New hypoglycemic drugs in treatment of diabetes type 2].
Sokup A; Swiatkowski M
Przegl Lek; 2000; 57(6):349-52. PubMed ID: 11107871
[TBL] [Abstract][Full Text] [Related]
8. [Glitazones clinical data: an update].
Guerci B
Ann Endocrinol (Paris); 2005 Apr; 66(2 Pt 2):1S45-58. PubMed ID: 15959404
[TBL] [Abstract][Full Text] [Related]
9. Oral antidiabetic agents: current role in type 2 diabetes mellitus.
Krentz AJ; Bailey CJ
Drugs; 2005; 65(3):385-411. PubMed ID: 15669880
[TBL] [Abstract][Full Text] [Related]
10. Thiazolidinediones: a review of their mechanisms of insulin sensitization, therapeutic potential, clinical efficacy, and tolerability.
Vasudevan AR; Balasubramanyam A
Diabetes Technol Ther; 2004 Dec; 6(6):850-63. PubMed ID: 15684639
[TBL] [Abstract][Full Text] [Related]
11. Glimepiride. A review of its use in the management of type 2 diabetes mellitus.
Langtry HD; Balfour JA
Drugs; 1998 Apr; 55(4):563-84. PubMed ID: 9561345
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of metabolite profiles as biomarkers for the pharmacological effects of thiazolidinediones in Type 2 diabetes mellitus patients and healthy volunteers.
van Doorn M; Vogels J; Tas A; van Hoogdalem EJ; Burggraaf J; Cohen A; van der Greef J
Br J Clin Pharmacol; 2007 May; 63(5):562-74. PubMed ID: 17488363
[TBL] [Abstract][Full Text] [Related]
13. Effects of combining linagliptin treatment with BI-38335, a novel SGLT2 inhibitor, on pancreatic islet function and inflammation in db/db mice.
Chen L; Klein T; Leung PS
Curr Mol Med; 2012 Sep; 12(8):995-1004. PubMed ID: 22804249
[TBL] [Abstract][Full Text] [Related]
14. Treating hyperglycemia in type 2 diabetes: new goals and strategies.
Lebovitz HE
Cleve Clin J Med; 2002 Oct; 69(10):809-20. PubMed ID: 12371804
[TBL] [Abstract][Full Text] [Related]
15. [Capabilities of hypoglycemic therapy in women with decompensated type 2 diabetes mellitus].
Onuchin SG; Elsukova OS; Solov'ev OV; Onuchina EL
Ter Arkh; 2010; 82(8):34-41. PubMed ID: 20873243
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological interventions that directly stimulate or modulate insulin secretion from pancreatic beta-cell: implications for the treatment of type 2 diabetes.
Farret A; Lugo-Garcia L; Galtier F; Gross R; Petit P
Fundam Clin Pharmacol; 2005 Dec; 19(6):647-56. PubMed ID: 16313276
[TBL] [Abstract][Full Text] [Related]
17. Durability of glycemic control: a feature of the thiazolidinediones.
Serdy S; Abrahamson MJ
Diabetes Technol Ther; 2004 Apr; 6(2):179-89. PubMed ID: 15117584
[TBL] [Abstract][Full Text] [Related]
18. A novel extract of Gymnema sylvestre improves glucose tolerance in vivo and stimulates insulin secretion and synthesis in vitro.
Al-Romaiyan A; King AJ; Persaud SJ; Jones PM
Phytother Res; 2013 Jul; 27(7):1006-11. PubMed ID: 22911568
[TBL] [Abstract][Full Text] [Related]
19. Type II diabetes mellitus.
Edelman SV
Adv Intern Med; 1998; 43():449-500. PubMed ID: 9506190
[TBL] [Abstract][Full Text] [Related]
20. Combination therapy with metformin plus vildagliptin in type 2 diabetes mellitus.
Guarino E; Nigi L; Patti A; Fondelli C; Dotta F
Expert Opin Pharmacother; 2012 Jun; 13(9):1377-84. PubMed ID: 22397507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
